Fitbit's paid subscription service announced this morning leverages the company's user data into actionable guidance and coaching aimed at improving movement, sleep, and diet, Craig-Hallum analyst Alex Fuhrman tells investors in a research note. The company's the healthcare opportunities discussed for years potentially represent a path towards a return to consistent revenue growth and profitability, adds the analyst. He continues to believe Fitbit is in the midst of a "significant evolution" in strategy and reiterates a Buy rating on the shares with a $7 price target.